|
|
 |
|
Viewing report
|
|
|
|
AMT (Amsterdam Molecular Therapeutics)-Detailed Product Pipeline
Life Science Analytics, March 2011, Pages: 46
AMT (Amsterdam Molecular Therapeutics)-Detailed Product Pipeline provides up to date insight into company’s business description, product information, pipeline details including both summary information and detailed individual product records.
Scope of the reports
Accessing accurate, current and comprehensive content on global public and private pipeline companies can be challenging however, Life Science Analytics has created a suite of reports that deliver the latest information on over 2,500 such companies. Each report provides a comprehensive description on business and product details of these companies.
Key benefits
Global Public & Private Company Pipeline Reports deliver independent insight into a company's business description, financials and products information - vital intelligence for investors, competitors and partners.
One stop shop for absolute information on a company’s product pipeline, cost and effort benefits.
Customers who bought this item also bought
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Product Pipeline Review - Q1 2011
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Product Pipeline Review - H2 2011
Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Product Pipeline Review - Q4 2010
Amsterdam Molecular Therapeutics (AMT) Holding N.V. (AMT) - Financial and Strategic SWOT Analysis Review
AMT (Amsterdam Molecular Therapeutics)-Therapeutic Competitors Report
Molecular Design International (MDI)-Detailed Product Pipeline
Pepscan Therapeutics-Detailed Product Pipeline
Wellstat Therapeutics Corporation-Detailed Product Pipeline
Adnexus Therapeutics-Detailed Product Pipeline
Tolera Therapeutics, Inc.-Detailed Product Pipeline
|
|
|
|
